BioCorRx
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of BioCorRx generated cash of -$1,853,282, which is more than the previous year. Cash used in financing activities reached the amount of $1,849,889 last year. Net change in cash is therefore -$3,393.
Cash Flow
| 2014 | 167.66K | -32.89K | -190.22K |
|---|---|---|---|
| 2015 | 47.85K | 0 | 119.08K |
| 2016 | -1.98M | -340.54K | 2.20M |
| 2017 | -2.54M | -2.97K | 2.41M |
| 2018 | -1.82M | -55.94K | 2.15M |
| 2019 | -2.93M | -121.79K | 5.42M |
| 2020 | -2.15M | -9.22K | 107.3K |
| 2021 | -3.53M | -49.99K | 3.08M |
| 2022 | -2.04M | 0 | 2.02M |
| 2023 | -1.85M | 0 | 1.84M |
BICX Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 68.61K | 85.83K | 592.05K | 2.64M | 279.77K | 11.34K | 142.45K | 220.06K | 53.12K | 108.56K |
Operating activities | ||||||||||
Net income | -3.76M | -4.37M | -5.21M | -3.50M | -6.04M | -6.58M | -29.70M | -5.90M | -4.66M | -3.12M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 199.93K | 141.96K | 168.94K | 166.77K | 96.50K | 7.35K | 33.88K | 30.24K | 125.07K | 135.49K |
Stock-based compensation expense | 277.05K | 354.50K | 209.51K | 355.04K | 1.96M | 0 | 830.78K | 582.34K | 802.92K | 1.98M |
| Deferred income tax benefit | 277.05K | 354.50K | 209.51K | 355.04K | 1.96M | 0 | 830.78K | 582.34K | 802.92K | 1.98M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 88.52K | -33.87K | -1K | 250 | 4.85K | -2.8K | -55.7K | -32K | -49.77K | 5.38K |
Inventories | 0 | 0 | -698.63K | -483.77K | -418.42K | -33.24K | -304.81K | 59.00K | -480.51M | -207.89M |
Accounts payable | 803.11K | 838.07K | 698.63K | 483.77K | 473.49K | 385.61K | 548.18K | -42.74K | 480.70M | 208.32M |
Cash generated by operating activities | -1.85M | -2.04M | -3.53M | -2.15M | -2.93M | -1.82M | -2.54M | -1.98M | 47.85K | 167.66K |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | 2 | 0 | -49.99K | -9.22K | -122.59K | -55.94K | -2.97K | -328.24K | 0 | -487 |
Acquisitions Net | 0 | 0 | 0 | 0 | 800 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 0 | 0 | -49.99K | -9.22K | -121.79K | -55.94K | -2.97K | -340.54K | 0 | -32.89K |
Financing activities | ||||||||||
Common Stock Issued | 915K | 1.25M | 2.25M | 0 | 100K | 0 | 940K | 100K | 0 | 172.5M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.13B | 0 |
Repayments of term debt | 934.88K | 774.55K | -831.44K | -107.3K | 0 | 0 | 1.47M | -564.41K | 119.08K | -45.07K |
Cash used in financing activities | 1.84M | 2.02M | 3.08M | 107.3K | 5.42M | 2.15M | 2.41M | 2.20M | 119.08K | -190.22K |
Net Change In Cash | -3.39K | -17.22K | -506.21K | -2.05M | 2.36M | 268.43K | -131.11K | -127.60K | 166.94K | -55.44K |
Cash at end of period | 65.22K | 68.61K | 85.83K | 592.05K | 2.64M | 279.77K | 11.34K | 92.45K | 220.06K | 53.12K |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |